Skip to main content

TEVA 5907 TEVA 5907 (Mesalamine Delayed-Release 400 mg)

Pill with imprint TEVA 5907 TEVA 5907 is Clear, Capsule-shape and has been identified as Mesalamine Delayed-Release 400 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Mesalamine is used in the treatment of crohn's disease, maintenance; inflammatory bowel disease; ulcerative colitis, maintenance; ulcerative colitis, active; ulcerative proctitis and belongs to the drug class 5-aminosalicylates. excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 5907 TEVA 5907

Mesalamine Delayed-Release

TEVA 5907 TEVA 5907
400 mg
Prescription only
Drug Class
Pregnancy Category
B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.